99 related articles for article (PubMed ID: 9807943)
21. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
Briscoe D; Rubowitz A; Assia E
Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and biological activity of novel antibacterial quinazolines.
Bedi PM; Kumar V; Mahajan MP
Bioorg Med Chem Lett; 2004 Oct; 14(20):5211-3. PubMed ID: 15380229
[TBL] [Abstract][Full Text] [Related]
23. [Analysis of predominant bacteria of burn infection and their resistance to antibiotics in recent years].
Li M; Zhang GA; Liu Y
Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):91-3. PubMed ID: 17649879
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial activity and pharmacokinetics/pharmacodynamics of the novel glycylcycline, tigecycline.
Peterson LR
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):163-4. PubMed ID: 16105559
[No Abstract] [Full Text] [Related]
25. Bacteriological study of neonatal septicaemia cases and their in vitro sensitivity to antimicrobial agents.
Chandna A; Chahar CK; Khatri PC; Miglani N
J Postgrad Med; 1984 Jul; 30(3):167-70. PubMed ID: 6481652
[No Abstract] [Full Text] [Related]
26. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial activity of enoxacin.
Nicoletti G; Caccamo F; Speciale A
J Chemother; 1989 Jul; 1(4 Suppl):143-4. PubMed ID: 16312344
[No Abstract] [Full Text] [Related]
28. Sensitivity of cefatrizine on clinical isolates of gram-positive, gram-negative cocci, Haemophilus, and Enterobacteriaceae.
Boisivon A; Perenet F; Guiomar C
J Chemother; 1989 Jul; 1(4 Suppl):304-5. PubMed ID: 16312412
[No Abstract] [Full Text] [Related]
29. Evaluation of bacterial sensitivity of chemoantibiotics by means of two semiautomatic systems. Cobas-bact and TTS.
Carbone M; Fera MT; Mastroeni P
J Chemother; 1989 Jul; 1(4 Suppl):1-4. PubMed ID: 16312278
[No Abstract] [Full Text] [Related]
30. Comparative activity of meropenem in US medical centers (2007): initiating the 2nd decade of MYSTIC program surveillance.
Jones RN; Kirby JT; Rhomberg PR
Diagn Microbiol Infect Dis; 2008 Jun; 61(2):203-13. PubMed ID: 18329835
[TBL] [Abstract][Full Text] [Related]
31. Occurrence of antimicrobial resistance in bacteria from diagnostic samples from dogs.
Pedersen K; Pedersen K; Jensen H; Finster K; Jensen VF; Heuer OE
J Antimicrob Chemother; 2007 Oct; 60(4):775-81. PubMed ID: 17644533
[TBL] [Abstract][Full Text] [Related]
32. Bacteraemia in 66 cats and antimicrobial susceptibility of the isolates (1995-2004).
Greiner M; Wolf G; Hartmann K
J Feline Med Surg; 2007 Oct; 9(5):404-10. PubMed ID: 17616416
[TBL] [Abstract][Full Text] [Related]
33. In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002.
Bouchillon SK; Hoban DJ; Johnson BM; Stevens TM; Dowzicky MJ; Wu DH; Bradford PA
Diagn Microbiol Infect Dis; 2005 Apr; 51(4):291-5. PubMed ID: 15808321
[TBL] [Abstract][Full Text] [Related]
34. Blood culture isolates and antimicrobial sensitivities from 427 critically ill neonatal foals.
Russell CM; Axon JE; Blishen A; Begg AP
Aust Vet J; 2008 Jul; 86(7):266-71. PubMed ID: 18616477
[TBL] [Abstract][Full Text] [Related]
35. Chronic wound infection and antimicrobial use.
Landis SJ
Adv Skin Wound Care; 2008 Nov; 21(11):531-40; quiz 541-2. PubMed ID: 18981758
[TBL] [Abstract][Full Text] [Related]
36. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
Streit JM; Jones RN; Sader HS; Fritsche TR
Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of Datura innoxia and Datura stramonium.
Eftekhar F; Yousefzadi M; Tafakori V
Fitoterapia; 2005 Jan; 76(1):118-20. PubMed ID: 15664475
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006.
Ishii Y; Yamaguchi K;
Diagn Microbiol Infect Dis; 2008 Jul; 61(3):346-50. PubMed ID: 18339507
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial activity of Inula helenium L. essential oil against Gram-positive and Gram-negative bacteria and Candida spp.
Deriu A; Zanetti S; Sechi LA; Marongiu B; Piras A; Porcedda S; Tuveri E
Int J Antimicrob Agents; 2008 Jun; 31(6):588-90. PubMed ID: 18450429
[No Abstract] [Full Text] [Related]
40. A study of the antimicrobial activity of selected naturally occurring and synthetic coumarins.
Smyth T; Ramachandran VN; Smyth WF
Int J Antimicrob Agents; 2009 May; 33(5):421-6. PubMed ID: 19155158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
